Vertical Research analyst Jeffrey Sprague downgrades Stanley Black & Decker (NYSE:SWK) from Buy to Hold.
ARCA biopharma Q2 EPS $(0.22) Up From $(0.34) YoY
ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.22) per share. This is a 35.29 percent increase over losses of $(0.34) per share from the same period last year.